181 related articles for article (PubMed ID: 23178713)
21. MicroRNA-708 is downregulated in hepatocellular carcinoma and suppresses tumor invasion and migration.
Li G; Yang F; Xu H; Yue Z; Fang X; Liu J
Biomed Pharmacother; 2015 Jul; 73():154-9. PubMed ID: 26211597
[TBL] [Abstract][Full Text] [Related]
22. Epigenetic activation of the MiR-200 family contributes to H19-mediated metastasis suppression in hepatocellular carcinoma.
Zhang L; Yang F; Yuan JH; Yuan SX; Zhou WP; Huo XS; Xu D; Bi HS; Wang F; Sun SH
Carcinogenesis; 2013 Mar; 34(3):577-86. PubMed ID: 23222811
[TBL] [Abstract][Full Text] [Related]
23. miR-200a suppresses cell growth and migration by targeting MACC1 and predicts prognosis in hepatocellular carcinoma.
Feng J; Wang J; Chen M; Chen G; Wu Z; Ying L; Zhuo Q; Zhang J; Wang W
Oncol Rep; 2015 Feb; 33(2):713-20. PubMed ID: 25482402
[TBL] [Abstract][Full Text] [Related]
24. MiR-219-5p inhibits hepatocellular carcinoma cell proliferation by targeting glypican-3.
Huang N; Lin J; Ruan J; Su N; Qing R; Liu F; He B; Lv C; Zheng D; Luo R
FEBS Lett; 2012 Mar; 586(6):884-91. PubMed ID: 22449976
[TBL] [Abstract][Full Text] [Related]
25. Androgen receptor (AR)/miR-520f-3p/SOX9 signaling is involved in altering hepatocellular carcinoma (HCC) cell sensitivity to the Sorafenib therapy under hypoxia via increasing cancer stem cells phenotype.
Xiao Y; Sun Y; Liu G; Zhao J; Gao Y; Yeh S; Gong L; Chang C
Cancer Lett; 2019 Mar; 444():175-187. PubMed ID: 30448543
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-124 suppresses growth of human hepatocellular carcinoma by targeting STAT3.
Lu Y; Yue X; Cui Y; Zhang J; Wang K
Biochem Biophys Res Commun; 2013 Nov; 441(4):873-9. PubMed ID: 24211205
[TBL] [Abstract][Full Text] [Related]
27. Acetylcholinesterase, a key prognostic predictor for hepatocellular carcinoma, suppresses cell growth and induces chemosensitization.
Zhao Y; Wang X; Wang T; Hu X; Hui X; Yan M; Gao Q; Chen T; Li J; Yao M; Wan D; Gu J; Fan J; He X
Hepatology; 2011 Feb; 53(2):493-503. PubMed ID: 21274871
[TBL] [Abstract][Full Text] [Related]
28. Expression and prognostic significance of vascular endothelial growth factor receptor 1 in hepatocellular carcinoma.
Li T; Zhu Y; Qin CY; Yang Z; Fang A; Xu S; Ren W
J Clin Pathol; 2012 Sep; 65(9):808-14. PubMed ID: 22734007
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-423 promotes cell growth and regulates G(1)/S transition by targeting p21Cip1/Waf1 in hepatocellular carcinoma.
Lin J; Huang S; Wu S; Ding J; Zhao Y; Liang L; Tian Q; Zha R; Zhan R; He X
Carcinogenesis; 2011 Nov; 32(11):1641-7. PubMed ID: 21890460
[TBL] [Abstract][Full Text] [Related]
30. Increased expression of OCT4 is associated with low differentiation and tumor recurrence in human hepatocellular carcinoma.
Dong Z; Zeng Q; Luo H; Zou J; Cao C; Liang J; Wu D; Liu L
Pathol Res Pract; 2012 Sep; 208(9):527-33. PubMed ID: 22824146
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-520e suppresses growth of hepatoma cells by targeting the NF-κB-inducing kinase (NIK).
Zhang S; Shan C; Kong G; Du Y; Ye L; Zhang X
Oncogene; 2012 Aug; 31(31):3607-20. PubMed ID: 22105365
[TBL] [Abstract][Full Text] [Related]
32. Expression of serum miR-221 in human hepatocellular carcinoma and its prognostic significance.
Li J; Wang Y; Yu W; Chen J; Luo J
Biochem Biophys Res Commun; 2011 Mar; 406(1):70-3. PubMed ID: 21295551
[TBL] [Abstract][Full Text] [Related]
33. Sox9 confers stemness properties in hepatocellular carcinoma through Frizzled-7 mediated Wnt/β-catenin signaling.
Leung CO; Mak WN; Kai AK; Chan KS; Lee TK; Ng IO; Lo RC
Oncotarget; 2016 May; 7(20):29371-86. PubMed ID: 27105493
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells.
Salvi A; Sabelli C; Moncini S; Venturin M; Arici B; Riva P; Portolani N; Giulini SM; De Petro G; Barlati S
FEBS J; 2009 Jun; 276(11):2966-82. PubMed ID: 19490101
[TBL] [Abstract][Full Text] [Related]
35. Expression features of SOX9 associate with tumor progression and poor prognosis of hepatocellular carcinoma.
Guo X; Xiong L; Sun T; Peng R; Zou L; Zhu H; Zhang J; Li H; Zhao J
Diagn Pathol; 2012 Apr; 7():44. PubMed ID: 22515642
[TBL] [Abstract][Full Text] [Related]
36. Cisplatin-induced downregulation of miR-199a-5p increases drug resistance by activating autophagy in HCC cell.
Xu N; Zhang J; Shen C; Luo Y; Xia L; Xue F; Xia Q
Biochem Biophys Res Commun; 2012 Jul; 423(4):826-31. PubMed ID: 22713463
[TBL] [Abstract][Full Text] [Related]
37. SOX9 is a proliferation and stem cell factor in hepatocellular carcinoma and possess widespread prognostic significance in different cancer types.
Richtig G; Aigelsreiter A; Schwarzenbacher D; Ress AL; Adiprasito JB; Stiegelbauer V; Hoefler G; Schauer S; Kiesslich T; Kornprat P; Winder T; Eisner F; Gerger A; Stoeger H; Stauber R; Lackner C; Pichler M
PLoS One; 2017; 12(11):e0187814. PubMed ID: 29121666
[TBL] [Abstract][Full Text] [Related]
38. miR-198 inhibits migration and invasion of hepatocellular carcinoma cells by targeting the HGF/c-MET pathway.
Tan S; Li R; Ding K; Lobie PE; Zhu T
FEBS Lett; 2011 Jul; 585(14):2229-34. PubMed ID: 21658389
[TBL] [Abstract][Full Text] [Related]
39. [miR-378 suppresses HBV-related hepatocellular carcinoma tumor growth by directly targeting the insulin-like growth factor 1 receptor].
Li LH; Gao Q; Wang XY; Guo ZJ
Zhonghua Gan Zang Bing Za Zhi; 2013 Aug; 21(8):609-13. PubMed ID: 24119742
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-1 and microRNA-499 downregulate the expression of the ets1 proto-oncogene in HepG2 cells.
Wei W; Hu Z; Fu H; Tie Y; Zhang H; Wu Y; Zheng X
Oncol Rep; 2012 Aug; 28(2):701-6. PubMed ID: 22664953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]